BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinsons disease
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at…
ACKO’s Grand Traffic Challan Report: Delhi Leads E Challan Fines
NEW DELHI, Oct. 6, 2025 /PRNewswire/ -- ACKO's Grand Traffic Challan Report…
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025 16:01 ET | Source: BridgeBio Pharma, Inc. PALO ALTO,…
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025 16:01 ET | Source: Intellia Therapeutics, Inc. CAMBRIDGE, Mass.,…
RMC Switchgears Limited Reports Q1 FY2025-26 PBT of 12.44 Crore, Maintains Strong Growth Momentum
JAIPUR, India, Sept. 19, 2025 /PRNewswire/ -- In a continuous endeavour to…
Bridgehold Surpasses 10,000 Intelligence Reports Delivered to Clients Worldwide
London, UK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Bridgehold, a blockchain security…
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 12, 2025 16:30 ET | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass.,…
Cango Inc. Reports Second Quarter 2025 Unaudited Financial Results
HONG KONG, Sept. 4, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) today announced…
Rackspace Technology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 05, 2025 18:00 ET | Source: Rackspace US, Inc. SAN ANTONIO,…
IOC Executive Board meeting 18 and 19 September 2025 Information for the media
05 September 2025 - The International Olympic Committee (IOC) Executive Board (EB) will hold a…
